MitoTEMPO hydrate

167 Cited Publications
Avis client

Based on 167 publication(s) in Google Scholar

MitoTEMPO hydrate is a mitochondria-targeted antioxidant. MitoTEMPO hydrate induces mitophagy by activating the PINK1/Parkin pathway, inhibits NLRP3 inflammasome activation, restores mitochondrial membrane potential, and improves renal function and podocyte injury. MitoTEMPO hydrate regulates Ca2+ homeostasis, inhibits Bnip3 overexpression, shortens action potential duration, and exerts antiarrhythmic effects. MitoTEMPO hydrate reverses premature senescence, reduces trabecular bone loss, and decreases cell apoptosis. MitoTEMPO hydrate can be used in studies of chronic kidney disease, age-related cardiac dysfunction, postmenopausal osteoporosis, and ischemic stroke.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Pureté: 98.03%
  • CAS No.: 1569257-94-8
  • Formule: C29H37ClN2O3P
  • Masse moléculaire:528.04
  • Stockage:

    -20°C, sealed storage, away from moisture

    * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

  • Activité biologique
  • Chemical Information
  • Pureté et documentation
  • Références
  • Help & FAQs
You May Still Need

Publications Citing Use of MedChemExpress (MCE) MitoTEMPO hydrate

More
Customer Validation & Images
WBIF
  • IF
  • WB
  • WB

Voir tous les produits spécifiques à Isoform NOD-like Receptor (NLR)

More
100 mg

Obtenir un devis En stock

Please select quantity
Amount: USD 0.00